Atherogenic and Residual Risk Pathway

Risk Enhancers Beyond LDL-C

1. The "ALIGN" Mnemonic for Residual Risk

When standard lipid panels fail to explain clinical presentation, think ALIGN: ApoB/ApoA1 ratio, Lp(a), Inflammation (hsCRP), Genetics (Family Hx), Nutrition (Homocysteine/B12).

2. The ApoB/ApoA1 Ratio (The INTERHEART Anchor)

LDL-C alone understates risk in South Asian patients, who often carry small, dense LDL particles: the same cholesterol is spread across a greater number of particles, and it is the particles that lodge in the artery wall.

• ApoB counts those particles directly. ApoA1 reflects protective HDL capacity.
• A ratio above 0.9 in men, or above 0.8 in women, marks a highly atherogenic phenotype and calls for the most stringent lipid targets the patient's risk group allows.
• One caution about where those two numbers come from. INTERHEART established the ratio as the strongest lipid predictor of myocardial infarction, reporting it in quintiles, with an odds ratio of 3.25 for the top quintile against the lowest. It did not itself publish a 0.9 and 0.8 cut-off. Those cut-points are in wide use and are usually traced to the AMORIS cohort, which was not read for this tool. They are used here on that basis.

3. Lipoprotein(a): The Genetic Intercept

Lp(a) is highly atherogenic and pro-thrombotic. Values above 50 mg/dL, or above 125 nmol/L where the laboratory reports in molar units, indicate profound, independent risk. Lp(a) itself will not move, so the response is to take down everything that will: drive the ApoB and LDL-C to the most stringent targets the Lipid Association of India sets for the patient's risk group.

4. Homocysteine & Endothelial Dysfunction

Elevated homocysteine in the Indian subcontinent is usually a B12 or folate deficiency, and strict vegetarian diets are the common reason. Finding it points to a nutritional deficit that can be corrected, and to a route of vascular damage running alongside the lipids.